A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
People, Not Technology are the Heart of London's Tech City
1 November 2012
By Stephen Caddick, Vice-Provost (Enterprise) at UCL
It's a rare thing to hear a resounding success story for UK Plc nowadays. Yet Tech City, the Government's anointed digital and media hub in East London, is just that.
Over the weekend, one of the Prime Minister's closest advisers, Rohan Silva, was talking up the initiative and this, combined with the appointment of Facebook's Joanna Shields - as the new Chief Executive of the Tech City Investment Organisation - was music to my ears.